21. P581: PHASE II STUDY OF LOWER-INTENSITY FRONTLINE THERAPY FOR NEWLY DIAGNOSED PATIENTS WITH AML WHO ARE UNFIT OR OTHERWISE NOT ELIGIBLE FOR FRONTLINE CLINICAL TRIALS. (23rd June 2022) Authors: Venugopal, S.; Jabbour, E.; Pemmaraju, N.; Montalban-Bravo, G.; Chien, K. S.; Daver, N.; Jain, N.; Burger, J.; Alvarado, Y.; Maiti, A.; DiNardo, C. D.; Borthakur, G.; Malla, R.; Garcia-Manero, G.; Ravandi, F.; Kantarjian, H.; Kadia, T. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. P695: PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN CHRONIC PHASE CML. (23rd June 2022) Authors: Bidikian, A.; Kantarjian, H.; Jabbour, E.; Short, N.; Ravandi, F.; Issa, G.; Sasaki, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. P703: ASSOCIATION BETWEEN BARIATRIC SURGERY AND OUTCOMES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH ORAL TYROSINE KINASE INHIBITORS. (23rd June 2022) Authors: Haddad, F.; Kantarjian, H.; Jabbour, E.; Short, N.; Bidikian, A.; Ning, J.; Xiao, L.; Pemmaraju, N.; Marx, K.; Ravandi, F.; Sasaki, K.; Issa, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA. (23rd June 2022) Authors: Bazinet, A.; Jabbour, E.; Kantarjian, H.; Chien, K.; DiNardo, C.; Ohanian, M.; Daver, N.; Kanagal-Shamanna, R.; Kadia, T.; Takahashi, K.; Masarova, L.; Short, N.; Alvarado, Y.; Thompson, P.; Montalban-Bravo, G.; Yilmaz, M.; Ravandi, F.; Konopleva, M.; Andreeff, M.; Kornblau, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. P760: PATTERNS OF HYPOMETHYLATING AGENT FAILURE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES. (23rd June 2022) Authors: Chien, K.; Kim, K.; Li, Z.; Kanagal Shamanna, R.; Ong, F.; Montalban Bravo, G.; Kadia, T.; Jabbour, E.; Pemmaraju, N.; Hammond, D.; Short, N.; Ravandi, F.; Alvarado, Y.; Pierce, S.; Dong, X. Q.; Kantarjian, H.; Garcia-Manero, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. P770: A COMPARATIVE STUDY OF LEUKEMIC TRANSFORMATION IN THERAPY-RELATED AND DE NOVO MYELODYSPLASTIC SYNDROME AFTER HYPOMETHYLATING AGENT FAILURE. (23rd June 2022) Authors: Kim, K.; Ong, F.; Li, Z.; Kanagal-Shamanna, R.; Montalban-Bravo, G.; Kadia, T.; Jabbour, E.; Pemmaraju, N.; Hammond, D.; Short, N.; Ravandi, F.; Alvarado, Y.; Pierce, S.; Dong, X. Q.; Kantarjian, H.; Garcia-Manero, G.; Chien, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. PB1831: UTILITY OF FLT3 INHIBITORS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND T(6;9)(P22;Q34). (23rd June 2022) Authors: Ong, F.; Kadia, T. M.; Short, N. J.; Yilmaz, M.; Alvarado, Y.; Pierce, S.; Garcia-Manero, G.; DiNardo, C.; Borthakur, G.; Konopleva, M.; Daver, N.; Kantarjian, H.; Ravandi, F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Persistence of Preleukemic Clonal Hematopoiesis after Chemotherapy is Associated with Poor Prognosis in Patients with High Risk MDS and AML. (April 2017) Authors: Takahashi, K.; Wang, F.; Patel, K.; Bueso-Ramos, C.; Issa, G.; Song, X.; Zhang, J.; Little, L.; Gumbs, C.; Ravandi, F.; Kadia, T.; Daver, N.; Konopleva, M.; Andreeff, M.; Cortes, J.; Garcia-Manero, G.; Jabbour, E.; Futreal, A.; Kantarjian, H. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Prognostic Impact of Mutations in Patients with Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms with Normal Karyotype. (April 2017) Authors: Montalban-Bravo, G.; Alfonso Pierola, A.; Takahashi, K.; Konopleva, M.; Jabbour, E.; Brothakur, G.; Daver, N.; DiNardo, C.; Estrov, Z.; Kadia, T.; Pemmaraju, N.; Ravandi, F.; Bueso-Ramos, C.; Kantarjian, H.; Patel, K.; Garcia-Manero, G. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. S114: PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE II STUDY. (23rd June 2022) Authors: Short, N.; Kantarjian, H.; Konopleva, M.; Jain, N.; Ravandi, F.; Huang, X.; Macaron, W.; Wierda, W.; Borthakur, G.; Kadia, T.; Sasaki, K.; Issa, G.; Montalban-Bravo, G.; Alvarado, Y.; Garcia-Manero, G.; Dinardo, C.; Thankachan, J.; Delumpa, R.; Mayor, E.; Deen, W. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗